Ramco-Gershenson Properties Trust Reports Financial and Operating Results for the Third Quarter 2016
Nov 01, 2016 20:15 pm UTC| Business
FARMINGTON HILLS, Mich., Nov. 01, 2016 -- Ramco-Gershenson Properties Trust (NYSE:RPT) today announced its financial and operating results for the three and nine months ended September 30, 2016. THIRD QUARTER 2016...
Telenav Reports First Quarter Fiscal 2017 Financial Results
Nov 01, 2016 20:15 pm UTC| Business
SANTA CLARA, Calif., Nov. 01, 2016 -- Telenav®, Inc. (NASDAQ:TNAV), a leader in connected car services, today announced its financial results for the first quarter that ended September 30, 2016. “For the first quarter...
Potbelly Corporation Reports Results for Third Fiscal Quarter 2016
Nov 01, 2016 20:15 pm UTC| Business
CHICAGO, Nov. 01, 2016 -- Potbelly Corporation (NASDAQ:PBPB) today reported financial results for the third fiscal quarter ended September 25, 2016. Key highlights for the thirteen weeks ended September 25, 2016...
Nov 01, 2016 20:15 pm UTC| Business
SAN MATEO, Calif., Nov. 01, 2016 -- WageWorks, Inc. (NYSE: WAGE), a leader in administering Consumer-Directed Benefits (CDBs), today announced it has signed definitive agreements to acquire Automatic Data Processing...
Hardinge Inc. Announces Retirement of John J. Perrotti from Board of Directors
Nov 01, 2016 20:15 pm UTC| Business
ELMIRA, N.Y., Nov. 01, 2016 -- The Board of Directors of Hardinge Inc. (NASDAQ:HDNG), a leading international provider of advanced metal-cutting solutions and accessories, announced that John J. Perrotti, Chairman, has...
Allied Motion Secures New $125 Million Credit Facility
Nov 01, 2016 20:15 pm UTC| Business
Refinancing expected to reduce annual cash interest expense by approximately $3.3 million on a pre-tax basis ($2.2 million after tax)New facility provides greater financial flexibility for acquisitions AMHERST, N.Y.,...
BeiGene to Participate in 25th Annual Credit Suisse Healthcare Conference
Nov 01, 2016 20:15 pm UTC| Business
WALTHAM, Mass., Nov. 01, 2016 -- BeiGene, Ltd. (Nasdaq:BGNE), a clinical-stage biopharmaceutical company developing innovative molecularly-targeted and immuno-oncological drugs for the treatment of cancer, today...